title: Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone.
abstract: The predominant community-associated MRSA strains vary between geographic settings, with ST8-IV USA300 being the commonest clone in North America, and the ST30-IV Southwest Pacific clone established as the dominant clone in New Zealand for the past two decades. Moreover, distinct epidemiological risk factors have been described for colonisation and/or infection with CA-MRSA strains, although these associations have not previously been characterized in New Zealand. Based on data from the annual New Zealand MRSA survey, we sought to describe the clinical and molecular epidemiology of MRSA in New Zealand. All non-duplicate clinical MRSA isolates from New Zealand diagnostic laboratories collected as part of the annual MRSA survey were included. Demographic data was collected for all patients, including age, gender, ethnicity, social deprivation index and hospitalization history. MRSA was isolated from clinical specimens from 3,323 patients during the 2005 to 2011 annual surveys. There were marked ethnic differences, with MRSA isolation rates significantly higher in Māori and Pacific Peoples. Over the study period, there was a significant increase in CA-MRSA, and a previously unidentified PVL-negative ST5-IV spa t002 clone replaced the PVL-positive ST30-IV Southwest Pacific clone as the dominant CA-MRSA clone. Of particular concern was the finding of several successful and virulent MRSA clones from other geographic settings, including ST93-IV (Queensland CA-MRSA), ST8-IV (USA300) and ST772-V (Bengal Bay MRSA). Ongoing molecular surveillance is essential to prevent these MRSA strains becoming endemic in the New Zealand healthcare setting.
authors: Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. dwilliamson@adhb.govt.nz
authors: Deborah A
authors: DA
authors: Williamson
authors: Sally A
authors: SA
authors: Roberts
authors: Stephen R
authors: SR
authors: Ritchie
authors: Geoffrey W
authors: GW
authors: Coombs
authors: John D
authors: JD
authors: Fraser
authors: Helen
authors: H
authors: Heffernan
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003695:Delivery of Health Care; D005260:Female; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics* / Q000302:isolation & purification* / Q000502:physiology; D008875:Middle Aged; D017720:Molecular Epidemiology; D058889:Molecular Typing; D009520:New Zealand / Q000453:epidemiology; D012111:Residence Characteristics / Q000706:statistics & numerical data*; D013045:Species Specificity; D013203:Staphylococcal Infections / Q000453:epidemiology*; D055815:Young Adult
references: N Z Med J. 1989 Jul 26;102(872):367-9
references: 2529458
references: Clin Infect Dis. 2009 Feb 1;48(3):274-84
references: 19137654
references: Emerg Infect Dis. 2001 Mar-Apr;7(2):178-82
references: 11294701
references: N Z Med J. 2011 Apr 15;124(1332):21-30
references: 21747420
references: Epidemiol Infect. 2011 Nov;139(11):1794-804
references: 21156094
references: J Antimicrob Chemother. 2002 Dec;50(6):825-31
references: 12461000
references: JAMA. 2007 Oct 17;298(15):1763-71
references: 17940231
references: J Clin Microbiol. 2005 Oct;43(10):5026-33
references: 16207957
references: Antimicrob Agents Chemother. 2012 Mar;56(3):1324-30
references: 22155818
references: Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S344-9
references: 18462089
references: J Clin Microbiol. 2000 Mar;38(3):1008-15
references: 10698988
references: Epidemiol Infect. 2005 Oct;133(5):899-904
references: 16181511
references: N Z Med J. 2012 May 11;125(1354):75-85
references: 22595927
references: J Pediatr Surg. 2010 Oct;45(10):1967-74
references: 20920714
references: Lancet. 2010 May 1;375(9725):1557-68
references: 20206987
references: Arch Intern Med. 2008 Jul 28;168(14):1585-91
references: 18663172
references: J Clin Microbiol. 2008 Feb;46(2):574-81
references: 18032612
references: Lancet. 2012 Mar 24;379(9821):1112-9
references: 22353263
references: J Clin Microbiol. 2010 Oct;48(10):3470-4
references: 20686081
references: J Clin Microbiol. 2012 Mar;50(3):841-7
references: 22189119
references: Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14130-5
references: 18772392
references: Clin Microbiol Rev. 2010 Jul;23(3):616-87
references: 20610826
references: N Engl J Med. 2007 Jul 26;357(4):380-90
references: 17652653
references: PLoS One. 2011 Apr 06;6(4):e17936
references: 21494333
references: BMC Microbiol. 2007 Oct 29;7:98
references: 17967176
references: Clin Infect Dis. 2008 Jun 15;46(12):1871-8
references: 18462175
references: Clin Infect Dis. 2011 Jan 1;52(1):99-114
references: 21148528
references: Aust N Z J Public Health. 1998 Dec;22(7):835-7
references: 9889455